Clinical Trial

IRONCARE: Iron Treatment in Older Patients With Hip Fractures

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of this study is to investigate the effects of intravenous (IV) iron therapy compared to alternate-day oral iron treatment and no supplementation in older patients with hip fractures. This study will examine the impact of iron treatment on fatigue, functional decline, fear of falling, cognitive impairment, and quality of life, as well as its effects on iron stores and hemoglobin levels, with the overall goal of improving postoperative rehabilitation. The trial will be conducted on five different hospitals in the Central Region of Denmark (Region Midtjylland).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-15.
Trial Details
NCT Number NCT07659184
Lead Sponsor University of Aarhus
Collaborators: Region MidtJylland Denmark, Viborg Regional Hospital, Gødstrup Hospital, Aarhus University Hospital, Randers Regional Hospital, Regionshospitalet Horsens
Conditions Hip Fracture, Anemia, Iron, Placebo - Control
Enrollment 528 participants
Start Date 2026-10-01
Primary Completion 2028-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-24